Krystal Biotech, Inc.
KRYS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001711279
In the last 90 days, Krystal Biotech, Inc. insiders filed 0 open-market purchases and 3 sales; 422 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Krystal Biotech, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 137
- +4 vs. Q1 2022
- Shares held
- 20.8M
- +228.8K (+1.1%) vs. Q1 2022
- Total value
- $1.36B
- −$1.46M (−0.1%) vs. Q1 2022
- New holders
- 19
- 46 more added
- Sold out
- 15
- 52 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRYS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 422 | $11.1B |
| Q1 2026 | 368 | $7.32B |
| Q4 2025 | 334 | $7.01B |
| Q3 2025 | 284 | $4.94B |
| Q2 2025 | 275 | $3.80B |
| Q1 2025 | 299 | $4.98B |
| Q4 2024 | 264 | $4.35B |
| Q3 2024 | 283 | $5.15B |
| Q2 2024 | 245 | $5.24B |
| Q1 2024 | 234 | $4.49B |
| Q4 2023 | 194 | $3.03B |
| Q3 2023 | 188 | $2.76B |
| Q2 2023 | 183 | $2.71B |
| Q1 2023 | 160 | $1.68B |
| Q4 2022 | 154 | $1.66B |
| Q3 2022 | 148 | $1.45B |
| Q2 2022 | 137 | $1.36B |
| Q1 2022 | 135 | $1.37B |
| Q4 2021 | 140 | $1.35B |
| Q3 2021 | 113 | $850.7M |
| Q2 2021 | 113 | $1.12B |
| Q1 2021 | 113 | $1.27B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Krystal Biotech, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,089 | $268.0K | 0.00% | −36−0.9% | Reduced |
| E Fund Management Co., Ltd. | 3,808 | $250.0K | 0.02% | +797+26.5% | Added |
| Franklin Resources Inc | 3,466 | $228.0K | 0.00% | −271−7.3% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 3,202 | $210.0K | 0.00% | +3,202 | New |
| Amalgamated Bank | 2,874 | $189.0K | 0.00% | +437+17.9% | Added |
| Tower Research Capital LLC (TRC) | 2,767 | $181.0K | 0.00% | −359−11.5% | Reduced |
| Virtus ETF Advisers LLC | 2,055 | $135.0K | 0.05% | −144−6.5% | Reduced |
| Amundi | 1,762 | $126.0K | 0.00% | +1,762 | New |
| Lazard Asset Management LLC | 1,844 | $120.0K | 0.00% | +73+4.1% | Added |
| Ameritas Investment Partners, Inc. | 1,560 | $102.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,283 | $84.2K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1,206 | $79.0K | 0.00% | −2,189−64.5% | Reduced |
| Nisa Investment Advisors, LLC | 1,060 | $70.0K | 0.00% | +800+307.7% | Added |
| Great West Life Assurance Co | 1,013 | $67.0K | 0.00% | 00.0% | Unchanged |
| International Biotechnology Trust PLC | 2,955 | $45.0K | 0.89% | −42,045−93.4% | Reduced |
| Macquarie Group Ltd | 628 | $41.0K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 406 | $27.0K | 0.00% | −265−39.5% | Reduced |
| Royal Bank of Canada | 289 | $19.0K | 0.00% | −1,243−81.1% | Reduced |
| Allspring Global Investments Holdings, LLC | 272 | $17.0K | 0.00% | −3,388−92.6% | Reduced |
| Cutler Group LP | 225 | $14.0K | 0.00% | −75−25.0% | Reduced |
| Captrust Financial Advisors | 155 | $10.0K | 0.00% | +102+192.5% | Added |
| Global Retirement Partners, LLC | 125 | $8.00K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 102 | $7.00K | 0.00% | +9+9.7% | Added |
| Advisor Group Holdings, Inc. | 97 | $6.00K | 0.00% | −3−3.0% | Reduced |
| TCI Wealth Advisors, Inc. | 84 | $6.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 96 | $6.00K | 0.00% | +20+26.3% | Added |
| State of Wyoming | 69 | $5.00K | 0.00% | −688−90.9% | Reduced |
| Ellevest, Inc. | 42 | $3.00K | 0.00% | +42 | New |
| Cubist Systematic Strategies, LLC | 37 | $2.00K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 42 | $2.00K | 0.00% | +42 | New |
| Federated Hermes, Inc. | 6 | $1.00K | 0.00% | 00.0% | Unchanged |
| Massmutual Trust Co FSB | 11 | $1.00K | 0.00% | 00.0% | Unchanged |
| AlphaMark Advisors, LLC | 10 | $1.00K | 0.00% | +10 | New |
| Lindbrook Capital, LLC | 5 | $0 | 0.00% | −7−58.3% | Reduced |
| Quadrant Capital Group LLC | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 4 | $0 | 0.00% | −1−20.0% | Reduced |
| Allworth Financial LP | 2 | $0 | 0.00% | +2 | New |
| Jennison Associates LLC | 0 | $0 | 0.00% | −68,309−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −25,310−100.0% | Sold out |
| DnB Asset Management AS | 0 | $0 | 0.00% | −24,500−100.0% | Sold out |
| Kynam Capital Management, LP | 0 | $0 | 0.00% | −18,393−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −8,732−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −6,186−100.0% | Sold out |
| Merriman Wealth Management, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −4,304−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −3,584−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −2,319−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| TCWP LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |